N

NovoCure Limited
D

NVCR

22.090
USD
0.42
(1.94%)
مغلق
حجم التداول
82,290
الربح لكل سهم
-2
العائد الربحي
-
P/E
-16
حجم السوق
2,390,169,677
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    AAPL
    AAPL
    -0.310
    (-0.13%)
    245.560 USD
    AMZN
    AMZN
    -6.305
    (-2.83%)
    216.495 USD
    GOOGL
    GOOGL
    -4.895
    (-2.65%)
    179.685 USD
    I
    ICUI
    -6.020
    (-3.69%)
    157.310 USD
    IDXX
    IDXX
    -0.33
    (-0.07%)
    452.66 USD
    ISRG
    ISRG
    -15.37
    (-2.53%)
    591.50 USD
    M
    MMSI
    -2.470
    (-2.34%)
    103.150 USD
    TSLA
    TSLA
    -16.87
    (-4.76%)
    337.50 USD
    المزيد
الأخبار
المقالات

العنوان: NovoCure Limited

القطاع: Healthcare
الصناعة: Medical Devices
NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatmentof solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derivesmajority of its revenue from the United States and rest from Germany, Japan and other markets.